Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - P/B ratio
P/B ratio as of May 2024 : -0.7594
According to Yield10 Bioscience's latest financial reports the company has a price-to-book ratio of -0.7594.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Yield10 Bioscience - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -1.15 | -161.55% |
| 2022-12-31 | 1.88 | 25.17% |
| 2021-12-31 | 1.50 | -25.87% |
| 2020-12-31 | 2.02 | -228.97% |
| 2019-12-31 | -1.57 | -207.33% |
| 2018-12-31 | 1.46 | 29.82% |
| 2017-12-31 | 1.12 | -27.77% |
| 2016-12-31 | 1.56 | -51.79% |
| 2015-12-31 | 3.23 | 9.14% |
| 2014-12-31 | 2.96 | 38.59% |
| 2013-12-31 | 2.14 | 99.16% |
| 2012-12-31 | 1.07 | -72.73% |
| 2011-12-31 | 3.93 | -71.55% |
| 2010-12-31 | 13.8 | 159.74% |
| 2009-12-31 | 5.32 | 7.68% |
| 2008-12-31 | 4.94 | -4.48% |
| 2007-12-31 | 5.17 | 54.38% |
| 2006-12-31 | 3.35 | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | 735.41% | Bahamas |
 NRC Health
NRC | 15.4 | -2,126.90% | 🇺🇸 USA |